Search results
Apr 15, 2024 · Paxlovid rebound, also known as COVID rebound, is a recurrence of COVID symptoms or a positive test result taken after having the disease and testing negative. Yale experts tell you what you need to know.
Aug 8, 2022 · The CDC defines Paxlovid rebound as when a patient who, after receiving a full five-day course of treatment, either has a reemergence of COVID symptoms or tests positive after a previous,...
Feb 20, 2024 · Does Paxlovid cause rebound symptoms? A CDC review of COVID rebound studies found “no consistent association between treatment and rebound.” Paxlovid does not directly cause symptoms to return; in fact, only about 1 in 5 people who take Paxlovid experience rebound , and many of those are asymptomatic.
Sep 26, 2023 · The theory behind Paxlovid rebound is that the treatment is so effective at suppressing the virus that the immune system does not ramp up its cellular and antibody...
Nov 13, 2023 · Paxlovid is an oral antiviral medication used to treat COVID-19. Previous studies demonstrate the medication’s effectiveness in reducing hospitalization and death in cases of severe COVID-19. Since the integration of Paxlovid into COVID-19 treatment, some patients have reported virologic rebound.
Mar 20, 2024 · One of the main open queries is about the role of the antiviral drug Paxlovid (nirmatrelvir and ritonavir), which aims to prevent mild or moderate COVID-19 from...
Paxlovid (nirmatrelvir tablets; ritonavir tablets) is a prescription oral antiviral drug that reduces the risk of hospitalization and death for patients with mild-to-moderate COVID-19 who are at risk of disease progression and severe illness (1).
